Recent news on Emtriva

California pharma firm banks on Indian companies  -  May 14, 2007
People's Daily Online,The agreements cover two drugs, Emtriva (emtricitabine) and Viread (tenofovirdisproxil fumarate), and allows the Indian partners to make any combination of

Gilead Sciences counts on Indian pharma companies  -  May 13, 2007
Moneycontrol.com,The agreements entered into since last September cover two drugs, Emtriva (emtricitabine) and Viread (tenofovir disoproxil fumarate), and allows the Indian

Royalty Pharma and InNexus Biotechnology Announce Agreement ...  -  Apr 26, 2007
Business Wire (press release),...including Abbott’s Humira®, Amgen’s Neupogen® and Neulasta®, Genentech’s Rituxan®, Gilead’s Emtriva®, Truvada® and Atripla®, and Celgene’s Thalomid®.

Royalty Pharma and InNexus Biotechnology Announce Agreement ...  -  26 Apr 2007
Genetic Engineering News (press release),Amgen's Neupogen(R) and Neulasta(R), Genentech's Rituxan(R), Gilead's Emtriva(R), Truvada(R) and Atripla(R), and Celgene's Thalomid(R).

Royalty Pharma and InNexus Biotechnology Announce Agreement ...  -  26 Apr 2007
Business Wire (press release),...including Abbott’s Humira®, Amgen’s Neupogen® and Neulasta®, Genentech’s Rituxan®, Gilead’s Emtriva®, Truvada® and Atripla®, and Celgene’s Thalomid®.

Gilead Sciences maakt eerstekwartaalcijfers 2007 bekend  -  Apr 19, 2007
Netherlands Corporate News (persbericht),Emtriva Emtriva(R) (emtricitabine) sales were $8.3 million for the first quarter of 2007, a decrease of 16 percent from $10.0 million in the first quarter

Gilead Sciences profit surges 55%  -  Apr 18, 2007
MarketWatchThe FDA approved Atripla, made up of Gilead's Truvada -- which consists of the company's drugs Viread and Emtriva -- and Bristol-Myers Squibb Co.'s (BMY :

Gilead Q1 Profit Soars 55% On Strong HIV Drug Sales  -  Apr 18, 2007
Trading Markets,Gilead's portfolio of HIV drugs includes Truvada, Atripla, Viread and Emtriva. The company's HIV product sales for the recent first quarter was $705.1

Gilead's Atripla, Lower Costs Provide Lift To First Quarter  -  Apr 22, 2007
BioWorld Online,Truvada - the combo HIV drug pairing Gilead's Viread (tenofovir disoproxil fumarate) and Emtriva (emtricitabine), did especially well in Europe.

Gilead quarterly profit, revenue seen up 43%  -  Apr 17, 2007
MarketWatchViread and Emtriva sales, meanwhile, are expected to slip sequentially, to $157.9 million and $8.4 million from fourth-quarter results of $159.5 million and

Gilead's revenue and profit up in Q1  -  Apr 19, 2007
Bizjournals.com,Sales of the HIV drugs Viread and Emtriva both fell 16 percent during the quarter. Gilead also sold drugs for Hepatitis B and for severe fungal infections

AIDS drug maker for the world producing around the clock at city plant  -  Apr 13, 2007
Edmonton Journal (subscription),Its four current AIDS drugs -- Viread, Emtriva, Truvada and Atripla -- were also launched from Edmonton and contributed more than $2 billion US to the

3 More Kings of Cash  -  Apr 23, 2007
Motley FoolAs the world's leader in HIV treatments, Gilead's dominant franchise of products (Altripla, Truvada, Viread, and Emtriva), lengthy patent protection,

Zacks Analyst Blog Highlights: Tweeter, Best Buy, Gilead Sciences ...  -  Apr 20, 2007
Business Wire (press release),The product combines Gilead's Truvada, itself a fixed-dose combination of Viread and Emtriva, and Sustiva, a non-nucleoside reverse transcriptase inhibitor

Analysis: Gilead's future looks bright  -  Apr 19, 2007
United Press International...treatment for HIV infection, and patients will be switched to Truvada and Viread as they develop resistance to Sustiva and Emtriva, respectively.

Gilead first quarter profit rises 55 pct  -  Apr 18, 2007
ReutersFirst-quarter sales of Viread and Emtriva, the two older HIV drugs used in the combination pills, fell 16 percent to $160.7 million and by 16 percent to

Standard screening tests may not detect hidden hepatitis B virus ...  -  27 Mar 2007
Aidsmap,...none of the participants with occult hepatitis B were taking antiretroviral drugs with anti-HBV activity, such as 3TC (Epivir), emtricitabine (Emtriva),

New HIV listings added to Pharmaceutical Schedule  -  Mar 14, 2007
Scoop.co.nz,Viread as well as Emtriva are for use in combination with other HIV medications for the treatment of HIV infection in adults. Viread is provided as a tablet

Gilead CEO Martin Receives $13.7 Million  -  Mar 23, 2007
Forbes,...based Gilead, which makes HIV drugs Truvada, Viread and Emtriva as well as partnering with Bristol-Myers Squibb (nyse: BMY - news - people ) on the

Gilead CEO Martin Receives $13.7 Million  -  Mar 23, 2007
Houston Chronicle,...based Gilead, which makes HIV drugs Truvada, Viread and Emtriva as well as partnering with Bristol-Myers Squibb on the combination HIV drug Atripla,

Ahead of the Bell: Merrill Ups Gilead  -  Mar 20, 2007
Forbes,Ende also touted the company's HIV treatments, which include Viread and Emtriva. "We view Gilead's HIV franchise as solid with a relatively low risk of

Gilead promotes two execs, including CFO  -  Mar 10, 2007
Bizjournals.com,Gilead sells the antiretroviral drugs Truvada, Viread and Emtriva. Viread has been sold in the United States since 2001, Emtriva since 2003 and Truvada

CDC: AIDS drugs hold promise for prevention  -  Mar 1, 2007
Inside Bay Area,But it might be a public health breakthrough if high doses of Viread and Emtriva are proven to be useful in protecting people from the AIDS virus, HIV.

HIV drugs to be subsidised  -  Mar 15, 2007
New Zealand Herald,The medicines, Tenofovir (Viread) and Emtricitabine (Emtriva), will be subsidised from April 1. Pharmac medical director Peter Moodie said the investment

Pharmac's new HIV drugs too slow - Aids foundation  -  Mar 14, 2007
Stuff.co.nz,Pharmac today announced two new medicines, Tenofovir (Viread) and emtricitabine (Emtriva), would be subsidised from April 1, 2007.

Two new medicines funded for people with HIV  -  Mar 14, 2007
Scoop.co.nz,Tenofovir (Viread) and emtricitabine (Emtriva) are comparatively new treatments that have similar actions to anti-HIV medicines that are already funded.

New HIV meds funded after delay  -  Mar 14, 2007
Scoop.co.nz,...tenofovir (Viread) and emtricitabine (Emtriva), but is disappointed at the length of time taken to approve one of the needed medications.

Anti-HBV drug entecavir also active against HIV and promotes ...  -  Mar 1, 2007
Aidsmap,Further, two approved anti-HIV drugs -- emtricitabine (Emtriva) and tenofovir (Viread) – are also active against HBV, and are in clinical trials for this

CROI: HIV Resistance Linked to Hepatitis Drug  -  Mar 1, 2007
MedPage Today,The M184V mutation confers resistance to lamivudine and emtricitabine (Emtriva). In the infectivity assay, Dr. Thio said, entecavir showed no effect against

Merck & Co., Inc. To Distribute ATRIPLA™ in Developing Countries  -  Feb 16, 2007
WebWire (press release),Emtricitabine and tenofovir disoproxil fumarate are commercialized by Gilead Sciences under the tradenames Emtriva® and Viread®, respectively.

Merck & Co., Inc. (1) To Distribute ATRIPLA(TM) in Developing ...  -  Feb 16, 2007
Genetic Engineering News (press release),Emtricitabine and tenofovir disoproxil fumarate are commercialized by Gilead Sciences under the tradenames Emtriva(R) and Viread(R), respectively.

Merck to sell AIDS pill in poor countries  -  Feb 20, 2007
Philadelphia Business Journal,The tablet combines three drugs in one pill -- Viread and Emtriva from Gilead, and Sustiva from Bristol-Myers Squibb Co. (NYSE:BMY) of New York.

Gilead Sciences swings to quarterly loss  -  Jan 31, 2007
MarketWatchThe FDA approved Atripla, which contains Bristol-Myers' Sustiva and Gilead's Truvada, which itself consists of the company's drugs Viread and Emtriva,

Gilead Sciences Announces Fourth Quarter and Full Year 2006 ...  -  Feb 1, 2007
PharmaLive.com (press release),Emtriva(R)(emtricitabine) sales were $8.5 million for the fourth quarter of 2006, a decrease of 24 percent from $11.2 million in the fourth quarter of 2005.

Gilead posts fourth-quarter net loss  -  Jan 31, 2007
ReutersFourth-quarter sales of Viread and Emtriva, the two older HIV drugs used in the combination pills, fell by 13 percent to $159.5 million and by 24 percent to

Zacks Analyst Blog Highlights: Home Depot, Lowe’s, Gilead Sciences ...  -  Feb 22, 2007
Business Wire (press release),We consider Truvada a reformulation of drugs Viread and Emtriva to be a potential breakthrough product for the treatment of HIV/AIDS.

Merck files triple-therapy HIV treatment in poorest countries  -  Feb 19, 2007
Pharma Times (subscription),...is delivered in a single tablet, and combines Bristol-Myers Squibb's Sustiva (efavirenz) and Gilead's Emtriva (emtricitabine) and Viread (tenofovir).

Merck pushes low-cost AIDS pill  -  Feb 17, 2007
NorthJersey.com,The tablet combines three drugs -- Gilead Sciences Inc.'s Viread and Emtriva and Bristol-Myers Squibb Co.'s Sustiva. Merck and Gilead, of Foster City,

Strong quarter boosts Gilead  -  Feb 12, 2007
Blogging StocksHe explains, "Gilead's HIV treatments (Viread, Truvada, Atripla, and Emtriva) were clear winners, with sales growing 67% to $642.4 million and surpassing

Gilead shares surge on 4th-quarter results  -  Feb 1, 2007
Durham Herald Sun,Gilead acquired Triangle in part to gain access to Emtriva for a combination therapy. Late Wednesday, the company reported a fourth-quarter loss due to

Gilead Sciences Posts Q4 Loss On Charges; EPS Beats View; Stock Up ...  -  Jan 31, 2007
Trading Markets,Atripla contributed $137.4 million, up 101% from last year, and Emtriva sales were down 24% to $8.5 million. Sales of AmBisome liposome for injection for

Earnings Preview: Gilead Sciences  -  Jan 29, 2007
Forbes,The company sells antiretrovirals Truvada, Viread and Emtriva and makes two of the three components to Atripla. BY THE NUMBERS: Analysts polled by Thomson

Top Picks 2007: Bill Martin "finds profits" at Gilead  -  Dec 27, 2006
Blogging StocksThe advisor explains, "Gilead is best known as a biopharmaceutical company with a leading HIV treatment franchise (Viread, Truvada, and Emtriva).

The Year in Review: Gilead Rises in 2006  -  Dec 27, 2006
Forbes,It combines Gilead's Truvada, which includes Viread and Emtriva, with Bristol-Myers Squibb (nyse: BMY - news - people )'s Sustiva and is the first

The Year In Review: Gilead rises in 2006  -  Dec 27, 2006
BusinessWeekIt combines Gilead's Truvada, which includes Viread and Emtriva, with Bristol-Myers Squibb's Sustiva and is the first once-a-day HIV treatment.

96-Week Data From Gilead's Study 934 Comparing Viread and Emtriva ...  -  Dec 15, 2006
PharmaLive.com (press release),..."The efficacy, safety and resistance profile of Viread/Emtriva/Sustiva in this study underscores the importance of this treatment option for antiretroviral

Market Report -- In Play (GILD)  -  Dec 15, 2006
MSN MoneyThis study compares a once-daily regimen of Viread, Emtriva and Sustiva to a twice-daily regimen of Combivir with Sustiva once daily.

Gilead Gets Subpoena Over HIV Drugs  -  Dec 8, 2006
Houston Chronicle,Truvada, which has been available in the US since 2004, combines Emtriva with Viread into a single daily tablet. Emtriva and Viread have been available in

US Attorneys in San Francisco Subpoena Records From Gilead for ...  -  Dec 12, 2006
Kaiser network.org,...the company's "marketing and medical education programs" for its antiretroviral drugs Emtriva, Truvada and Viread, the Contra Costa Times reports.

Gilead subpoenaed over drug marketing  -  Dec 9, 2006
Therapeutics Daily (subscription) (press release),Truvada is a combination of Viread and Emtriva, also known respectively as tenofovir and emtricitabine. "Gilead intends to comply with the US Attorney's

Gilead Gets Subpoena Over HIV Drugs  -  Dec 8, 2006
CBS 5,Federal investigators are seeking documents concerning marketing and medical education programs for Gilead's HIV treatments Truvada, Viread and Emtriva.

Leading maker of AIDS drugs Gilead hit with subpoena  -  Dec 8, 2006
San Diego Union Tribune,The company said it will give federal prosecutors the documents they demand connected to the drugs Truvada, Viread and Emtriva and it plans “to cooperate in

Gilead subpoenaed over HIV drugs  -  Dec 8, 2006
MarketWatch...said late Thursday it has been asked for documents concerning its marketing and medical education programs for Viread and Emtriva, as well as for Truvada,

Gilead gets subpoena over anti-HIV drugs  -  Dec 9, 2006
The Advocate,Gilead issued a statement saying the subpoena requested documents for its medications Truvada, Viread, and Emtriva. Company officials said they intended to

Gilead gets subpoena over HIV drugs  -  Dec 7, 2006
ReutersGilead, in a statement, said the subpoena requested documents for its medications Truvada, Viread and Emtriva. The company said it intended to comply with

Gilead Gets Subpoena  -  Dec 7, 2006
TheStreet.com...the attorney's office has requested documents relating to its marketing and medical education programs for HIV treatments Viread, Emtriva and Truvada.

Leading maker of AIDS drugs Gilead hit with subpoena  -  Dec 8, 2006
Fort Worth Star Telegram,The company said it will give federal prosecutors the documents they demand connected to the drugs Truvada, Viread and Emtriva and it plans "to cooperate in

Gilead Sciences Receives Subpoena from US Department of Justice  -  Dec 8, 2006
PharmaLive.com (press release),...programs for Truvada(R) (emtricitabine and tenofovir disoproxil fumarate), Viread(R) (tenofovir disoproxil fumarate) and Emtriva(R) (emtricitabine).

Gilead Sciences Receives Subpoena from US Department of Justice  -  Dec 7, 2006
Business Wire (press release),...programs for Truvada ® (emtricitabine and tenofovir disoproxil fumarate), Viread ® (tenofovir disoproxil fumarate) and Emtriva ® (emtricitabine).

Gilead Stock Jumps After Analyst Upgrade  -  Dec 4, 2006
Forbes,...based Gilead makes several HIV treatments, including Viread, Emtriva and Truvada. Gilead contributes two of three components of a once-a-day HIV treatment

Tenofovir DF- and Thymidine Analog-Containing Regimens Display ...  -  Dec 14, 2006
DG News3TC) or emtricitabine (Emtriva). The antiretroviral naive women in the analysis were enrolled in 2 prospective, randomized studies (study 903 and 934).

Why did HIV therapy have some benefits for a man with resistance ...  -  Dec 12, 2006
Aidsmap,A genotypic resistance test detected resistance to all the available antiretroviral drugs except 3TC (lamivudine, Epivir), FTC (emtricitabine, Emtriva) and

Genentech Inks $300M Alzheimer's Antibody Deal and Biogen Says ...  -  Dec 11, 2006
Financial News USA (press release),...served Gilead with a subpoena for documents concerning marketing and medical education programs for the HIV treatments Truvada, Viread and Emtriva.

Bristol-Myers Squibb, Gilead Sciences And Merck & Co. Submit ...  Oct 10, 2006
...under the tradename Stocrin(R). Emtricitabine and tenofovir disoproxil fumarate are commercialized by Gilead Sciences under the tradenames Emtriva(R) and Viread ... -Medical News Today (press release), Source: Bristol-Myers Squibb Company  Oct 8, 2006
Emtricitabine and tenofovir disoproxil fumarate are commercialized by Gilead Sciences under the tradenames Emtriva® and Viread®, respectively. ... -Yahoo! News (press release) Bristol-Myers Squibb, Gilead Sciences and Merck & Co. Submit ...  Oct 8, 2006
...under thetradename Stocrin(R). Emtricitabine and tenofovir disoproxil fumarate arecommercialized by Gilead Sciences under the tradenames Emtriva(R) andViread(R ... -Earthtimes.org Gilead Sciences meldt derde kwartaalresultaten 2006  Oct 18, 2006
Emtriva Emtriva(R) (emtricitabine) sales were $9.3 million for the third quarter of 2006, down 21 percent from the third quarter of 2005. ... -Netherlands Corporate News (persbericht), Gilead Sciences posts net loss, sales jump  Oct 18, 2006
...of three existing HIV drugs -- Bristol-Myers' Sustiva and Gilead's Truvada, which itself consists of the company's drugs Viread and Emtriva -- was approved by ... -MarketWatch Atripla Makers Seek European Approval  Oct 9, 2006
The once-daily pill combines efavirenz, sold under the Bristol trade name Sustiva, emtricitabine, known by the Gilead brand name Emtriva, and tenofovir, sold ... -TheStreet.com Garden State Business Briefs  Oct 9, 2006
The drug is a combination of fixed doses of three HIV treatments -- Bristol-Myers' Sustiva, and Gilead's Viread and Emtriva. Sustiva ... -Newark Star Ledger, Gilead Sciences Announces Third Quarter 2006 Financial Results  Oct 18, 2006
Emtriva ® (emtricitabine) sales were $9.3 million for the third quarter of 2006, down 21 percent from the third quarter of 2005. ... -Business Wire (press release), Bristol-Myers Profit Falls as Plavix Copy Hurts Sales (Update5)  Oct 26, 2006
In July, the agency cleared Atripla, a once-a-day pill for HIV combining Bristol-Myers's Sustiva with Gilead Sciences Inc.'s Viread and Emtriva medicines. ... -Bloomberg 3 Drugmakers Seek EU OK for HIV Drug  Oct 9, 2006
The drug is a combination of fixed doses of three HIV treatments _ Bristol-Myers' Sustiva, and Gilead's Viread and Emtriva. Sustiva ... -Houston Chronicle, Bristol-Myers, Gilead Sciences, Merck Submit Marketing ...  Oct 9, 2006
Further, Gilead Sciences has commercialized Emtricitabine and tenofovir disoproxil fumarate under the tradenames Emtriva and Viread, respectively. ... -Trading Markets, Gilead Q3 2006 Earnings Call Transcript  Oct 18, 2006
For our entire HIV franchise, which includes Viread, Emtriva, Truvada and now Atripla, we’re slightly raising our full-year 2006 guidance for net product ... -Seeking Alpha, Royalty Pharma Announces Agreement Regarding the Purchase of the ...  Oct 26, 2006
...high-quality blockbuster biopharmaceutical products, including Amgen's Neupogen® and Neulasta®, Genentech's Rituxan®, Gilead's Emtriva®, Truvada® and ... -Yahoo! News (press release) Royalty Pharma Announces Agreement Regarding the Purchase of the ...  Oct 26, 2006
...several high-quality blockbuster biopharmaceutical products, including Amgen's Neupogen(R) and Neulasta(R), Genentech's Rituxan(R), Gilead's Emtriva(R), Truvada ... -PharmaLive.com (press release), UPDATE 1-Gilead Sciences posts third-quarter loss  Oct 18, 2006
Sales of Viread and Emtriva, the two older HIV drugs used in the combination pills, fell 10 percent to $170.6 million and 21 percent to $9.3 million ... -Reuters Media Advisory - Gilead Sciences Announces full Availability of ...  Oct 12, 2006
Truvada is a fixed-dose combination product containing two Gilead anti-HIV medications, Emtriva(R) (emtricitabine) and Viread(R) (tenofovir disoproxil fumarate ... -Canada NewsWire (press release), DeKalb Business Briefs – WaMu to close branches, new funding for ...  Sep 12, 2006
Dr. Liotta discovered three drugs that are now commercial, including Gilead’s highly successful Emtriva, part of the world’s top selling HIV cocktail ... -GoDeKalb.com

Metastatix, Inc. Completes Series A Financing, HIG Ventures Leads ...  Sep 7, 2006
Dr. Liotta discovered three drugs that are now commercial, including Gilead ’s highly successful Emtriva, part of the world’s top selling HIV cocktail ... -TechLINKS

Search for a Cure: Chemical Condoms: an Update  Sep 6, 2006
This is a once a day antiviral made by Gilead Sciences. It is a combination of two drugs, Viread (tenofovir) and Emtriva (emtracitibine). ... -The Empty Closet

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional